InvestorsHub Logo
Post# of 252522
Next 10
Followers 50
Posts 6343
Boards Moderated 0
Alias Born 01/22/2006

Re: DewDiligence post# 36587

Tuesday, 10/31/2006 3:15:03 AM

Tuesday, October 31, 2006 3:15:03 AM

Post# of 252522
Sirna-027 has hardly anything in common with those early gene-therapy experiments. It is administered locally in the eye and does not use a viral vector

Didn't mean to imply Sirna's drug had Leukemia risks, just new technology wondering how much known about safety profile. I don't claim to understand the science to know the risks (if any).

Dry AMD per se is not such an awful condition that it warrants the kinds of aggressive interventions that are justified for people with the wet form of the disease.
It may not lead to blindness like wet, in and of itself but with greatly impacted vision leading to significant loss in quality of life oh and a much greater prevelance I think a drug for Dry AMD (not just stopping progression) would do quite well. Yeah a drug to stop progression would be nice too.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.